|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
1994-12-6
|
|
pubmed:abstractText |
Vertical partial laryngectomy (VPL) and radiation therapy (RT) are the recommended conventional conservative options for glottic carcinoma classified as T2. In series presenting more than 100 patients with a minimum 3-year follow-up, however, local recurrence rates were reported as 22-43.5%. The authors' experience with a new strategy based on continuous cisplatin-fluorouracil induction chemotherapy (IC) and supracricoid partial laryngectomy with cricohyoepiglottopexy (CHEP) is presented.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
74
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2781-90
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:7954237-Adult,
pubmed-meshheading:7954237-Aged,
pubmed-meshheading:7954237-Aged, 80 and over,
pubmed-meshheading:7954237-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:7954237-Carcinoma,
pubmed-meshheading:7954237-Chemotherapy, Adjuvant,
pubmed-meshheading:7954237-Cisplatin,
pubmed-meshheading:7954237-Female,
pubmed-meshheading:7954237-Fluorouracil,
pubmed-meshheading:7954237-Glottis,
pubmed-meshheading:7954237-Humans,
pubmed-meshheading:7954237-Infusions, Intravenous,
pubmed-meshheading:7954237-Laryngeal Neoplasms,
pubmed-meshheading:7954237-Laryngectomy,
pubmed-meshheading:7954237-Lymphatic Metastasis,
pubmed-meshheading:7954237-Male,
pubmed-meshheading:7954237-Middle Aged,
pubmed-meshheading:7954237-Neoplasm Recurrence, Local,
pubmed-meshheading:7954237-Neoplasm Staging,
pubmed-meshheading:7954237-Remission Induction,
pubmed-meshheading:7954237-Retrospective Studies,
pubmed-meshheading:7954237-Survival Analysis,
pubmed-meshheading:7954237-Treatment Outcome
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
A clinical trial of continuous cisplatin-fluorouracil induction chemotherapy and supracricoid partial laryngectomy for glottic carcinoma classified as T2.
|
|
pubmed:affiliation |
Department of Otorhinolaryngology-Head and Neck Surgery, Laënnec Hospital, University of Paris V, France.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
